NCT05783466

Dairy Lipids and Cardiometabolic Risk

Bioactive Dairy Lipids to Manage Cardiometabolic Risk in Obesity

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: Hospices Civils de Lyon · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

It is a randomized parallel arm intervention study in adults with severe obesity. The objective is to demonstrate that within a dietary handling for weight loss, the daily ingestion during 3 months of whole dairy products enriched with milk polar lipids or whole dairy products decreases to a greater extent fasting plasma apolipoprotein B concentrations than the daily ingestion of low-fat dairy products (control group). Metabolic parameters will be assessed before and after the 3-month intervention, both at fasting and in postprandial period after the consumption of standardized meals.

Conditions

• Morbid Obesity

Interventions

Type	Name	Description
OTHER	Low-fat dairy products	3-month intervention
OTHER	Whole-fat dairy products	3-month intervention
OTHER	Milk polar lipid enriched whole-fat dairy products	3-month intervention

Timeline

• Start date: 2023-06-28
• Primary completion: 2026-10-01
• Completion: 2026-10-01
• First posted: 2023-03-24
• Last updated: 2025-06-18

Locations

2 sites across 1 country: France